Navidea Biopharmaceuticals Inc (NAVB) stock is higher by 239.47% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives NAVB stock a score of 71 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 98. NAVB's rank also includes a fundamental score of 86. In addition to the average rating from Wall Street analysts, NAVB stock has a mean target price of 7.5. This means analysts expect the stock to gain 190.70% over the next 12 months. The long-term technical score for NAVB is 28.
What's Happening with NAVB Stock Today
Navidea Biopharmaceuticals Inc (NAVB) stock is higher by 2.38% while the S&P 500 is higher by 0.08% as of 11:15 AM on Thursday, Oct 22. NAVB is higher by $0.06 from the previous closing price of $2.52 on volume of 28,320 shares. Over the past year the S&P 500 is higher by 14.44% while NAVB is higher by 239.47%. NAVB lost -$0.56 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Navidea Biopharmaceuticals Inc (NAVB) Stock.
